MCRB
Seres Therapeutics, Inc.stockNASDAQ
Market OpenNov 16, 2026 9:53:15 AM EST
1.63USD+16.429%(+0.23)34,936
MCRB Financials
In Q3 FY 2026 (ended ), Seres Therapeutics, Inc. (MCRB) reported revenue of $593K, net income of −$16.29M, operating cash flow of −$10.48M, and assets of $65.89M (filed ).
Loading business breakdowns…
